Oral Elacestrant Requires Patient Education in Metastatic ER+ Breast Cancer
Nausea and upper GI discomfort are frequently linked with use of the oral SERD.
COVID-19 and Cancer: Oncologist Shares His View
Aditya Bardia, MD, MPH, attending physician at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses COVID-19 (Coronavirus) risk in patients with cancer and the elderly.
Utilizing Actionable Classifications in TNBC
While physicians are looking to further subclassify TNBC to narrow treatment options, not all of these classifications are actionable in the clinic.
Immune Engager Therapies Improve Responses, PFS in RRMM After CAR T-Cell Therapy
Liso-Cel Elicits Rapid, Durable Responses in Relapsed/Refractory CLL/SLL
Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment
Ruxolitinib Plus Belumosudil Confers a 55% Response Rate in GVHD
2 Commerce Drive Cranbury, NJ 08512